NCT03871088View on ClinicalTrials.gov

N-3 Fatty Acids as the First-line Antidepressant Therapy: From Biomarkers to Clinical Subtypes

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2018

Conditions
Major Depressive Disorder
Interventions
DIETARY_SUPPLEMENT

Omega-3 fatty acids

12-week double-blind, randomized controlled trial

Trial Locations (1)

404

China Medical University Hospital, Taichung

All Listed Sponsors
lead

National Science and Technology Council, Taiwan

OTHER_GOV

NCT03871088 - N-3 Fatty Acids as the First-line Antidepressant Therapy: From Biomarkers to Clinical Subtypes | Biotech Hunter | Biotech Hunter